Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Eli Lilly and Co and T1D Exchange announce research collaboration to advance diabetes care


Wednesday, 9 Apr 2014 08:00am EDT 

T1D Exchange and Eli Lilly and Co:Parties enters into research collaboration.Will enable both parties to gain deeper, real-world insight about experience of people with type 1 diabetes, to identify new ways to improve care and advance outcomes.Organizations will engage in range of projects that combine Lilly's long history of and expertise in type 1 diabetes with T1D Exchange's innovative, patient-centric model.Collaboration will involve multiple projects over an initial five-year period. 

Company Quote

68.12
0.8 +1.19%
28 Nov 2014